Firm strengthens engineering resources to support private LLM deployments, AI automation, and enterprise data pipelinesSeattle-Tacoma, WA, ...

A software engineer and book author with many years of experience, I have dedicated my career to the art of automation. A software engineer and book author with many years of experience, I have ...

The South Florida Water Management District's Python Elimination Program announced its October winners. Hunter Donna Kalil captured the most pythons in October with 21, earning her a bonus award.

What’s the best way to bring your AI agent ideas to life: a sleek, no-code platform or the raw power of a programming language? It’s a question that sparks debate among developers, entrepreneurs, and ...

The Python Software Foundation has rejected a $1.5 million government grant because of anti-DEI requirements imposed by the Trump administration, the nonprofit said in a blog post yesterday. The grant ...

On October 3, 2025, the U.S. Food and Drug Administration (FDA) announced a prioritization pilot program for reviewing abbreviated new drug applications (ANDAs). ANDAs are submissions for generic ...

remove-circle Internet Archive's in-browser video "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on. Please see your ...

Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...

Oct 3 (Reuters) - The U.S. Food and Drug Administration said on Friday it has launched a new pilot program to speed up the review process for generic drugs that are tested and manufactured entirely in ...

A U.S. flag, a U.S. Food and Drug Administration (FDA) logo, a syringe and a vial are seen in this illustration taken May 13, 2025. REUTERS/Dado Ruvic/Illustration (Reuters) -The U.S. Food and Drug ...

Against a backdrop of tariff updates and a drug pricing deal from the Trump administration, the FDA charted a pair of moves this week in its push to make drug manufacturing more attractive in the U.S.